CD-MEDICS
Coeliac Disease – Management, Monitoring and Diagnosis using Biosensors and an Integrated Chip System
| Coordinatore | UNIVERSITAT ROVIRA I VIRGILI
Organization address
address: c./ Escorxador S/N N/A contact info |
| Nazionalità Coordinatore | Spain [ES] |
| Totale costo | 12˙702˙594 € |
| EC contributo | 9˙500˙000 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Code Call | FP7-ICT-2007-1 |
| Funding Scheme | CP |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-02-01 - 2012-07-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
UNIVERSITAT ROVIRA I VIRGILI
Organization address
address: c./ Escorxador S/N N/A contact info |
ES (Tarragona) | coordinator | 0.00 |
| 2 |
ASOCIACION DE CELIACOS DE MADRID
Organization address
address: CALLE LANUZA 19 contact info |
ES (MADRID) | participant | 0.00 |
| 3 |
ASSOCIATION OF EUROPEAN COELIAC SOCIETIES
Organization address
address: AVENUE LOUIS BERTRAND 100 A20 contact info |
BE (BRUXELLES) | participant | 0.00 |
| 4 |
CLEMENS GMBH
Organization address
address: DACHDECKERSTRASSE 5 contact info |
DE (WALDBUETTELBRUNN) | participant | 0.00 |
| 5 |
COELIAC UK
Organization address
address: SUITES A-D OCTAGON COURT HIGHT WYCOMBE contact info |
UK (BUCKINGHAMSHIRE) | participant | 0.00 |
| 6 |
EUROSPITAL SPA
Organization address
address: 122 VIA FLAVIA contact info |
IT (TRIESTE) | participant | 0.00 |
| 7 |
FONDAZIONE IRCCS POLICLINICO SAN MATTEO
Organization address
address: VIALE GOLGI contact info |
IT (PAVIA) | participant | 0.00 |
| 8 |
INNO-TRAIN DIAGNOSTIK GMBH
Organization address
address: NIEDERHOECHSTAEDTER STRASSE 62 contact info |
DE (KRONBERG) | participant | 0.00 |
| 9 |
INSTITUT FUER MIKROTECHNIK MAINZ GMBH
Organization address
address: Carl-Zeiss-Str. contact info |
DE (Mainz) | participant | 0.00 |
| 10 |
INTRACOM SA TELECOM SOLUTIONS
Organization address
address: New Road Peania Markopoulo Ave. contact info |
EL (PEANIA) | participant | 0.00 |
| 11 |
IXSCIENT LIMITED
Organization address
address: POPES GROVE contact info |
UK (TWICKENHAM MIDDLESEX) | participant | 0.00 |
| 12 |
KING'S COLLEGE LONDON
Organization address
address: Strand contact info |
UK (LONDON) | participant | 0.00 |
| 13 |
MICROFLUIDIC CHIPSHOP GMBH
Organization address
address: STOCKHOLMER STRASSE contact info |
DE (JENA) | participant | 0.00 |
| 14 |
MIKROSYSTIMATA MIKROROIS GIA GENETIKOUS ELEGKOUS KAI MORIAKI DIAGNOSTIKI EE
Organization address
address: PATRIARCHOU GRIGORIOU TECHNOLOGIKO PARKO DIMOKRITOS contact info |
EL (AGHIA PARASKEVI) | participant | 0.00 |
| 15 |
MULTID ANALYSES AB
Organization address
address: LOTSGATAN 5 A contact info |
SE (GOTEBORG) | participant | 0.00 |
| 16 |
SUOMEN PUNAINEN RISTI
Organization address
address: TEHTAANKATU 1 A contact info |
FI (HELSINKI) | participant | 0.00 |
| 17 |
TATAA BIOCENTER AB
Organization address
address: ODINSGATAN contact info |
SE (GOTEBORG) | participant | 0.00 |
| 18 |
UNIVERSITY OF NEWCASTLE UPON TYNE
Organization address
address: Kensington Terrace contact info |
UK (NEWCASTLE UPON TYNE) | participant | 0.00 |
| 19 |
Univerzitetni klinicni center Maribor
Organization address
address: LJUBLJANSKA ULICA 5 contact info |
SI (MARIBOR) | participant | 0.00 |
| 20 |
VALENTIA TECHNOLOGIES
Organization address
address: UNIT B07, NUTGROVE ENTERPRISE PARK, NUTGROVE WAY,RATHFARNHAM contact info |
IE (DUBLIN) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
The overall concept of the CD-MEDICS IP is to develop a technology platform for point-of-care diagnostics, capable of simultaneous genomic and proteomic detection, with embedded communication abilities for direct interfacing with hospital information systems. This will be achieved by exploiting breakthroughs at the confluences of bio-, micro- and nano- technologies to create a low-cost non-invasive intelligent diagnosis system. This platform will be developed in a modular format, which will allow each module to be developed and exploited individually. The modules will subsequently be integrated to facilitate the desired application. Advances in data communications, molecular biology and biosensor technology, with the integration of nanostructured functional components in macro and microsystems, will facilitate the realisation of a minimally invasive generic platform, which is capable of multi-parametric monitoring and will be interoperable with electronic medical records. The advantages of integrated biosensor systems include their ease of use, their sensitivity, their inherent selectivity (preventing problems due to interfering substances), their versatility (allowing 'in-field' use) and their cost effectiveness. Addressing the future health care requirement of an individualised theranostic approach, the specific application that will be demonstrated in this IP will be for the management, monitoring and diagnosis of coeliac disease, with the proposed technology contributing to significant advances in sensitivity and specificity of diagnosis. The technology platform developed, however, could be applied to a variety of clinical screening applications, such as cancer. The radical innovation proposed in this IP will result in a concrete prime deliverable of a technology platform of wide application and unquestionable socio-economic benefit, increasing European competitiveness whilst contributing considerably to the quality of life well-being of the population.